Clinical trial
Nicotine Lozenges for Treatment of Smokeless Tobacco Addiction
NCT00392379 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00392379 |
|---|---|
| Title | Nicotine Lozenges for Treatment of Smokeless Tobacco Addiction |
| Official title | Evaluating Nicotine Lozenges for Treatment of Smokeless Tobacco Addiction |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Smokeless Tobacco Use |
| Intervention type | Drug |
| Interventions | Nicotine Lozenges, Placebo lozenge |
| Enrollment | 270 |
| Start date | Jan 1, 2007 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Oct 26, 2006 |
| Last update posted | Apr 24, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: